Conference Proceedings
PSMA and FDG PET as Predictive and Prognostic Biomarkers in Men with Metastatic, Castration-Resistant Prostate Cancer (mCRPC): an Analysis of the Randomised, Phase 2 Trial of [177Lu]Lu-PSMA-617 Versus Cabazitaxel (TheraP, ANZUP 1603)
J Buteau, A Martin, L Emmett, A Iravani, S Sandhu, AM Joshua, RJ Francis, AY Zhang, AM Scott, S Lee, A Azad, M McJannett, MR Stockler, S Williams, ID Davis, MS Hofman
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | SPRINGER | Published : 2022